Literature DB >> 34199367

Mechanisms of TDP-43 Proteinopathy Onset and Propagation.

Han-Jou Chen1, Jacqueline C Mitchell2.   

Abstract

TDP-43 is an RNA-binding protein that has been robustly linked to the pathogenesis of a number of neurodegenerative disorders, including amyotrophic lateral sclerosis and frontotemporal dementia. While mutations in the TARDBP gene that codes for the protein have been identified as causing disease in a small subset of patients, TDP-43 proteinopathy is present in the majority of cases regardless of mutation status. This raises key questions regarding the mechanisms by which TDP-43 proteinopathy arises and spreads throughout the central nervous system. Numerous studies have explored the role of a variety of cellular functions on the disease process, and nucleocytoplasmic transport, protein homeostasis, RNA interactions and cellular stress have all risen to the forefront as possible contributors to the initiation of TDP-43 pathogenesis. There is also a small but growing body of evidence suggesting that aggregation-prone TDP-43 can recruit physiological TDP-43, and be transmitted intercellularly, providing a mechanism whereby small-scale proteinopathy spreads from cell to cell, reflecting the spread of clinical symptoms observed in patients. This review will discuss the potential role of the aforementioned cellular functions in TDP-43 pathogenesis, and explore how aberrant pathology may spread, and result in a feed-forward cascade effect, leading to robust TDP-43 proteinopathy and disease.

Entities:  

Keywords:  ALS; TDP-43; frontotemporal dementia; neurodegeneration; proteinopathy

Mesh:

Substances:

Year:  2021        PMID: 34199367      PMCID: PMC8199531          DOI: 10.3390/ijms22116004

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  144 in total

1.  TDP-43 levels are higher in platelets from patients with sporadic amyotrophic lateral sclerosis than in healthy controls.

Authors:  Miki Hishizawa; Hirofumi Yamashita; Mayumi Akizuki; Makoto Urushitani; Ryosuke Takahashi
Journal:  Neurochem Int       Date:  2018-12-20       Impact factor: 3.921

2.  TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons.

Authors:  Seiichi Nagano; Junki Jinno; Rehab F Abdelhamid; Yinshi Jin; Megumi Shibata; Shohei Watanabe; Sachiko Hirokawa; Masatoyo Nishizawa; Kenji Sakimura; Osamu Onodera; Hironori Okada; Takashi Okada; Yuko Saito; Junko Takahashi-Fujigasaki; Shigeo Murayama; Shuji Wakatsuki; Hideki Mochizuki; Toshiyuki Araki
Journal:  Acta Neuropathol       Date:  2020-08-16       Impact factor: 17.088

3.  A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions.

Authors:  Yoshiaki Furukawa; Kumi Kaneko; Shoji Watanabe; Koji Yamanaka; Nobuyuki Nukina
Journal:  J Biol Chem       Date:  2011-03-24       Impact factor: 5.157

Review 4.  Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases.

Authors:  Yu Tang; Weidong Le
Journal:  Mol Neurobiol       Date:  2015-01-20       Impact factor: 5.590

5.  Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.

Authors:  Sami J Barmada; Gaia Skibinski; Erica Korb; Elizabeth J Rao; Jane Y Wu; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

6.  Exosome secretion is a key pathway for clearance of pathological TDP-43.

Authors:  Yohei Iguchi; Lara Eid; Martin Parent; Geneviève Soucy; Christine Bareil; Yuichi Riku; Kaori Kawai; Shinnosuke Takagi; Mari Yoshida; Masahisa Katsuno; Gen Sobue; Jean-Pierre Julien
Journal:  Brain       Date:  2016-09-27       Impact factor: 13.501

7.  Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection.

Authors:  S Eréndira Avendaño-Vázquez; Ashish Dhir; Sara Bembich; Emanuele Buratti; Nicholas Proudfoot; Francisco E Baralle
Journal:  Genes Dev       Date:  2012-08-01       Impact factor: 11.361

8.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.

Authors:  Han-Xiang Deng; Wenjie Chen; Seong-Tshool Hong; Kym M Boycott; George H Gorrie; Nailah Siddique; Yi Yang; Faisal Fecto; Yong Shi; Hong Zhai; Hujun Jiang; Makito Hirano; Evadnie Rampersaud; Gerard H Jansen; Sandra Donkervoort; Eileen H Bigio; Benjamin R Brooks; Kaouther Ajroud; Robert L Sufit; Jonathan L Haines; Enrico Mugnaini; Margaret A Pericak-Vance; Teepu Siddique
Journal:  Nature       Date:  2011-08-21       Impact factor: 49.962

9.  Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD.

Authors:  Michael E Ward; Alice Taubes; Robert Chen; Bruce L Miller; Chantelle F Sephton; Jeffrey M Gelfand; Sakura Minami; John Boscardin; Lauren Herl Martens; William W Seeley; Gang Yu; Joachim Herz; Anthony J Filiano; Andrew E Arrant; Erik D Roberson; Timothy W Kraft; Robert V Farese; Ari Green; Li Gan
Journal:  J Exp Med       Date:  2014-08-25       Impact factor: 14.307

10.  Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis.

Authors:  Phillip Smethurst; Emmanuel Risse; Giulia E Tyzack; Jamie S Mitchell; Doaa M Taha; Yun-Ru Chen; Jia Newcombe; John Collinge; Katie Sidle; Rickie Patani
Journal:  Brain       Date:  2020-02-01       Impact factor: 13.501

View more
  2 in total

1.  The Protective Effect of Edaravone on TDP-43 Plus Oxidative Stress-Induced Neurotoxicity in Neuronal Cells: Analysis of Its Neuroprotective Mechanisms Using RNA Sequencing.

Authors:  Aki Soejima-Kusunoki; Kinya Okada; Ryuta Saito; Kazuhiko Watabe
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-08

2.  Analysis of the Biomarkers for Neurodegenerative Diseases in Aged Progranulin Deficient Mice.

Authors:  Xiangli Zhao; Sadaf Hasan; Benjamin Liou; Yi Lin; Ying Sun; Chuanju Liu
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.